Clinical Trial Update: Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis. [NA]

View source ↗

Summary

Completed clinical trial evaluating the efficacy and tolerability of a topical MD based on SHBF for radiodermatitis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatitis
• Radiation Dermatitis

Drugs mentioned

• Topical MD based on SHBF

Snippet

Sponsor: Relife Italia S.r.l. | Conditions: Radiodermatitis, Dermatitis, Radiation-Induced | NA | Status: COMPLETED | Results posted: 2025-05-15